Verus Capital Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $922K | Sell |
1,183
-174
| -13% | -$136K | 0.08% | 159 |
|
|
2025
Q1 | $1.12M | Sell |
1,357
-490
| -27% | -$405K | 0.1% | 135 |
|
|
2024
Q4 | $1.43M | Sell |
1,847
-29
| -2% | -$22.4K | 0.13% | 103 |
|
|
2024
Q3 | $1.66M | Buy |
1,876
+53
| +3% | +$47K | 0.15% | 92 |
|
|
2024
Q2 | $1.65M | Buy |
1,823
+543
| +42% | +$492K | 0.16% | 97 |
|
|
2024
Q1 | $996K | Buy |
1,280
+60
| +5% | +$46.7K | 0.11% | 118 |
|
|
2023
Q4 | $711K | Sell |
1,220
-54
| -4% | -$31.5K | 0.09% | 133 |
|
|
2023
Q3 | $684K | Sell |
1,274
-229
| -15% | -$123K | 0.1% | 126 |
|
|
2023
Q2 | $705K | Buy |
1,503
+321
| +27% | +$151K | 0.1% | 121 |
|
|
2023
Q1 | $406K | Buy |
1,182
+111
| +10% | +$38.1K | 0.06% | 180 |
|
|
2022
Q4 | $392K | Buy |
1,071
+184
| +21% | +$67.3K | 0.07% | 175 |
|
|
2022
Q3 | $287K | Buy |
887
+147
| +20% | +$47.6K | 0.05% | 207 |
|
|
2022
Q2 | $239K | Buy |
740
+1
| +0.1% | +$323 | 0.05% | 244 |
|
|
2022
Q1 | $218K | Buy |
+739
| New | +$218K | 0.03% | 289 |
|
|
2020
Q1 | $135K | Sell |
970
-573
| -37% | -$79.7K | 0.04% | 253 |
|
|
2019
Q4 | $203K | Buy |
+1,543
| New | +$203K | 0.07% | 234 |
|